Absorption |
Blood-Brain Barrier | BBB+ | 0.9856 |
Human Intestinal Absorption | HIA+ | 0.9941 |
Caco-2 Permeability | Caco2+ | 0.8141 |
P-glycoprotein Substrate | Substrate | 0.8014 |
P-glycoprotein Inhibitor | Inhibitor | 0.7675 |
Non-inhibitor | 0.6972 |
Renal Organic Cation Transporter | Inhibitor | 0.5404 |
Distribution |
Subcellular localization | Mitochondria | 0.4851 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8015 |
CYP450 2D6 Substrate | Substrate | 0.6542 |
CYP450 3A4 Substrate | Substrate | 0.7365 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6385 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8491 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.6089 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8195 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8295 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5115 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9342 |
Non-inhibitor | 0.8712 |
AMES Toxicity | Non AMES toxic | 0.6584 |
Carcinogens | Non-carcinogens | 0.9549 |
Fish Toxicity | High FHMT | 0.9867 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9566 |
Honey Bee Toxicity | Low HBT | 0.5864 |
Biodegradation | Not ready biodegradable | 0.9862 |
Acute Oral Toxicity | III | 0.7998 |
Carcinogenicity (Three-class) | Non-required | 0.6065 |